Learn About Fabry Disease Inheritance and Family Screening

Fabry disease is a rare inherited disorder caused by changes in the GLA gene, which can reduce the activity of an enzyme called alpha galactosidase A. The condition can affect several organs, including the kidneys, heart, skin, eyes, and nervous system. Because Fabry disease can be passed through families.

Fabry disease is a genetic condition associated with variants in the GLA gene, which provides instructions for producing the enzyme alpha galactosidase A. When this enzyme is deficient or significantly reduced, a fatty substance called globotriaosylceramide can accumulate in cells and tissues. The condition can vary considerably between individuals, even within the same family. Some people develop symptoms during childhood, while others may not be diagnosed until adulthood. Understanding the genetic basis of Fabry disease is therefore important when considering testing and family screening.

Understanding Fabry Disease Inheritance

Fabry disease is generally inherited in an X linked pattern because the GLA gene is located on the X chromosome. Both males and females can be affected, although symptoms and their severity can differ substantially.

In a male with a disease causing GLA variant on his X chromosome, all of his daughters inherit his X chromosome, while his sons inherit his Y chromosome. A woman with a disease causing GLA variant can potentially pass the variant to both sons and daughters.

Important inheritance considerations include:

  • Fabry disease is associated with changes in the GLA gene on the X chromosome.
  • Affected males pass their GLA variant to all daughters but not to sons.
  • Females with a GLA variant can pass it to both male and female children.
  • Symptoms can differ significantly among relatives who carry the same genetic variant.
  • A family history may help healthcare professionals recognize relatives who could benefit from evaluation.

Genetic counseling can help families understand inheritance patterns, possible implications of genetic testing, and the meaning of test results.

Family Screening and Genetic Testing

When Fabry disease is identified in one family member, healthcare professionals may recommend evaluating other biological relatives. Family screening can be particularly relevant because some people carrying a GLA variant may have mild, unusual, or initially unrecognized symptoms.

Screening may involve different approaches depending on the person's age, sex, symptoms, and family history:

  • Genetic testing can identify disease associated GLA variants.
  • Enzyme activity testing can help evaluate alpha galactosidase A activity, particularly in males.
  • Clinical assessments may evaluate kidney, heart, neurological, skin, and eye findings.
  • Family history review can help identify relatives who may warrant further assessment.
  • Genetic counseling can help explain test results and their potential implications for relatives.

Testing should be interpreted by appropriately qualified healthcare professionals because finding a genetic variant does not necessarily predict exactly how severe or when symptoms will become. Similarly, a person may have Fabry disease even when symptoms are not obvious.

Family screening can provide information that helps healthcare professionals determine whether additional monitoring is appropriate. It can also help relatives understand their potential genetic risk and make informed decisions about discussing testing with their healthcare providers.

Fabry disease inheritance can have implications for multiple generations of a family. Recognizing the X linked inheritance pattern and considering appropriate family screening may help identify relatives who could benefit from evaluation and monitoring. Genetic testing, enzyme testing, clinical assessments, and genetic counseling can each contribute useful information. Because Fabry disease can vary widely between individuals, screening decisions and test results should be interpreted in the context of a person's family history and clinical findings. This information is educational and is not a substitute for individualized medical advice, diagnosis, or treatment from a qualified healthcare professional.

Related Articles